Boston Sci, J&J Bury The Hatchet In Guidant Acquisition Dispute
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific will pay Johnson & Johnson $600 million to settle allegations that cardiovascular device firm Guidant breached a merger agreement with J&J in 2006, a far cry from the $7 billion sought by J&J